File articles

reducir costos de angioplastia

Is it possible to reduce PCI costs without compromising safety?

Is it possible to reduce PCI costs without compromising safety?

Courtesy of Dr. Carlos Fava. Health system costs have increased significantly and there have been attempts to reduce it without compromising the quality of PCI outcomes. The benefits of the transradial approach combined with same day discharge could help reach this goal.   This study included 279,987 MEDICARE PCI procedures where costs were analyzed. Cases

Zotarolimus con polímero permanente vs. biolimus con polímero degradable

Zotarolimus with Durable Polymer vs. Biolimus with Biodegradable Polymer

The present work compared the safety and efficacy of the permanent polymer zotarolimus eluting stent vs. the biodegradable polymer biolimus eluting stent in unselected coronary artery disease patients.   The biodegradable polymer biolimus eluting stent resulted superior to the first generation durable polymer stent in long term randomized studies.  However, little evidence supports this superiority

stent-liberador-de-zotarolimus

RESOLUTE Global: 5 Years of Zotarolimus DES Stenting

This study assessed the cumulative incidence of cardiovascular evens after zotarolimus eluting stent implantation.   Individual studies often lack enough statistical power to show differences in low frequency adverse events. The Resolute zotarolimus eluting stent was evaluated across 10 prospective clinical trials designed with identical adverse events definitions.   The Global Resolute clinical trial program

Isquemia crítica de miembros inferiores: el blush de la herida

Critical Limb Ischemia: Wound Blush Is the Most Important Objective

The aim of this study was to find the optimal angiographic endpoint for infrapopliteal interventions to be able to predict wound healing.   Evidence shows acceptable patency and successful limb salvage in patients with critical limb ischemia after infrapopliteal intervention. However, the optimal angiographic endpoint remains unclear. Is it enough to restore flow in one

angioplastia de la arteria femoral común

A new alternative for PCI of the common femoral artery

Courtesy of Dr. Carlos Fava. Not long ago, atherosclerosis of the common femoral artery used to be treated surgically and, thanks to better training and new balloon devices, we have advanced the endovascular treatment alternative. However, severe calcification continues to be a great limitation.   This study aimed at evaluating the feasibility and one year

Marcapaseo con la guía 0.035” TAVI

Pacing with a 0.035” Guidewire, an Old Technique Coming Back to Simplify TAVR

This study seeks to prove the safety and efficacy of rapid left ventricular pacing through a 0.035” guidewire during aortic valvuloplasty and transcatheter aortic valve replacement (TAVR).   Right ventricular temporary pacing placed through venous access during aortic valvuloplasty or during TAVR is time-consuming and, above all, associated with cardiac perforation and tamponade.   Since

desensibilizacion a la aspirina

Aspirin Desensitization in Patients with Coronary Artery Disease

There are limited data on aspirin desensitization in patients with coronary artery disease (CAD). The aim of this study was to test the safety and efficacy of a rapid desensitization protocol inpatients with a history of aspirin sensitivity about to receive PCI.   This was a prospective multicenter observational study, carried out in seven Italian

MitraClip frecuencia ritmo cardíaco

MitraClip: Impact of Sinus Rhythm and Heart Rate

Courtesy of Dr. Carlos Fava. Atrial fibrillation (AF) and fast heart rate (>70 lpm) have been shown to increase the risk of mitral valve repair surgery. The MitraClip has shown benefits in high risk patients, but its relation to abnormal heart rhythm has not yet been established.   760 patients were analyzed; 315 (52.4%) presented

proteccion_cerebral_tavr

Cerebral Protection in TAVR: Does It Improve Cognitive Function?

Neurological complications during transcatheter aortic valve replacement (TAVR) may be reduced with cerebral protection devices; this study was designed to explore that hypothesis.   The study enrolled 363 patients undergoing TAVR in 19 sites and divided them in three arms: a safety arm (n = 123), a device imaging arm (n = 121), and a non-device imaging arm (n = 119).   The

protecion cerebral en tavr

Meta-analysis on Cerebral Embolic Protection in TAVR

Cerebral embolic protection is a strategy to prevent embolization of thrombotic or calcific debris during transcatheter aortic valve replacement (TAVR). A number of randomized and controlled studies have tested the safety and efficacy of various devices, though none of them have enough statistical power to show significant differences in end points.     While preliminary

Top